Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
RNA Directed DNA Polymerase Inhibitor
100%
Human Immunodeficiency Virus 1
100%
Nonnucleoside Reverse Transcriptase Inhibitor
75%
Acquired Immune Deficiency Syndrome
50%
Diseases
25%
Anti-Human Immunodeficiency Virus
25%
Elvucitabine
25%
Apricitabine
25%
Stavudine
25%
Delavirdine
25%
Didanosine
25%
Dapivirine
25%
Doravirine
25%
Efavirenz
25%
Emtricitabine
25%
Nevirapine
25%
Zidovudine
25%
Elsulfavirine
25%
RNA Directed DNA Polymerase
25%
Binding Site
25%
Adverse Event
25%
Keyphrases
Reverse Transcriptase Inhibitors
100%
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
60%
Nucleoside Reverse Transcriptase Inhibitors
60%
Human Immunodeficiency Virus/acquired Immunodeficiency Syndrome
20%
Stavudine
20%
Efavirenz
20%
Dapivirine
20%
Drug Intervention
20%
Delavirdine
20%
Didanosine
20%
Nevirapine
20%
Elsulfavirine
20%
Zidovudine
20%
Doravirine
20%